Andreas Nandy

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2010-2018.

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

14 out of 3,020

Merck Patent Gmbh

patents

Years Active: 2010-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9975932 - Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues (2018-05-22),

2. 9789178 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4 (2017-10-17),

3. 9556241 - DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods (2017-01-31),

4. 9522938 - Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity (2016-12-20),

5. 9309297 - DNA sequence, and recombinant preparation of group 4 major allergens from cereals (2016-04-12),

6. 9120866 - DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods (2015-09-01),

7. 8999348 - Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues (2015-04-07),

8. 8945530 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4 (2015-02-03),

9. 8628946 - Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity (2014-01-14),

10. 8420097 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4 (2013-04-16),

11. 8263090 - [object Object] (2012-09-11),

12. 8128935 - DNA sequence and recombinant production of the grass pollen allergen Phl p 4 (2012-03-06),

13. 7935347 - DNA sequence, and recombinant preparation of group 4 major allergens from cereals (2011-05-03),

14. 7846448 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4 (2010-12-07),

Title: The Innovations of Andreas Nandy

Introduction

Andreas Nandy is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of allergen research, holding a total of 14 patents. His work focuses on developing innovative solutions to reduce allergenicity in grass pollen, which has important implications for allergy sufferers.

Latest Patents

Nandy's latest patents include groundbreaking inventions such as "Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues." This invention relates to the preparation and use of recombinant variants of group 5 allergens of the Poaceae, characterized by reduced IgE reactivity while retaining T-lymphocyte reactivity. Another notable patent is "DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4." This invention provides a DNA sequence of the major grass pollen allergen Lol p 4, including fragments and new combinations that exhibit hypoallergenic properties. These recombinant DNA molecules can be utilized for the therapy of pollen-allergic diseases and for diagnostic purposes.

Career Highlights

Throughout his career, Nandy has worked with reputable companies such as Merck Patent GmbH and Allergopharma GmbH & Co. KG. His experience in these organizations has allowed him to advance his research and contribute to the development of effective treatments for allergies.

Collaborations

Nandy has collaborated with notable colleagues, including Helmut Fiebig and Oliver Cromwell. These partnerships have fostered innovation and have been instrumental in his research endeavors.

Conclusion

Andreas Nandy's contributions to allergen research and his innovative patents highlight his commitment to improving the lives of those affected by pollen allergies. His work continues to pave the way for advancements in allergy treatment and diagnosis.